RxDoctor Payments DataLook up a doctor →

Vinod Jona, MD

Pulmonary Disease · Florence, SCNPI 1154361723

Payments from drug & device makers

$78,182in general payments, 2019–2025

Across 557 payments — averaging $140.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$59K
  • Intuitive Surgical$7K
  • Sanofi$3K
  • AstraZeneca$2K
  • Veran Medical Technologies, Inc.$959
  • Olympus Corporation Of The Americas$910
  • plus $5K from 45 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
GSK163$59,434
Intuitive Surgical59$7,232
Sanofi22$3,182
AstraZeneca(2 entities)84$1,950
Veran Medical Technologies, Inc.3$959
Olympus Corporation Of The Americas8$910
Regeneron Healthcare Solutions, Inc.17$377
Boehringer Ingelheim20$354
Mallinckrodt Hospital Products Inc.17$332
Actelion Pharmaceuticals US, Inc.14$255
Galvanize Therapeutics, Inc3$232
Philips North America LLC11$190
Genentech USA, Inc.9$173
Electromed, Inc.14$171
United Therapeutics Corporation8$163
Merck7$149
Johnson & Johnson4$148
Grifols USA, LLC6$128
Sunovion Pharmaceuticals Inc.9$125
Harmony Biosciences LLC6$122
Baxter Healthcare5$118
Steris Corporation1$116
Amgen5$100
Covidien LP1$96
ANI Pharmaceuticals, Inc.5$91
Jazz Pharmaceuticals Inc.4$90
Insmed, Inc.5$87
Advanced Respiratory, Inc6$87
Verona Pharma, Inc.4$84
Mylan Specialty L.p.5$82
Shionogi Inc3$76
Olympus America Inc.1$62
Inogen, Inc.2$50
Viatris Specialty LLC2$45
Mallinckrodt Enterprises LLC3$43
Avadel CNS Pharmaceuticals, LLC2$43
Vifor Pharma, Inc.2$42
Novartis2$38
Resmed Corp1$34
Ambu Inc.2$32
Pfizer2$25
Pharming Healthcare, Inc.1$24
La Jolla Pharmaceutical Company1$22
UCB, Inc.1$19
Lilly USA, LLC1$15
Shire North American Group Inc1$14
Takeda Pharmaceuticals U.S.A., Inc.1$14
E.r. Squibb & Sons, L.L.C.1$14
Circassia Inc.1$12
Bayer1$12
Astellas Pharma US Inc1$11

How this compares

$78,182 in reported general payments places this provider in the 80th percentile of 192 pulmonary disease providers in South Carolina.

See all pulmonary disease providers in South Carolina →

Medicare billing

Part B allowed, 2024
$587,951
Medicare patients
1,491
Services billed
6,470

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other pulmonary disease in Florence

See the full list for South Carolina →

Where these figures come from

Is this you, or does something look wrong? →